[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Imatinib Drugs Market Report 2017

August 2017 | 101 pages | ID: A5D0D9255FEEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Imatinib Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Imatinib Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Imatinib Drugs market competition by top manufacturers/players, with Imatinib Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Apotex Inc.
  • Novartis
  • Sanofi S.A.
  • Cipla Inc.
  • Mylan Pharms Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Sun Pharmaceuticals
  • Actavis Generics
  • Dr. Reddy's Laboratories
  • Teva Pharmaceutical Industries Ltd.
On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
  • Capsules
  • Tablets
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Imatinib Drugs for each application, includin
  • Hospitals
  • Drug Stores
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Imatinib Drugs Market Report 2017

1 IMATINIB DRUGS OVERVIEW

1.1 Product Overview and Scope of Imatinib Drugs
1.2 Classification of Imatinib Drugs by Product Category
  1.2.1 Asia-Pacific Imatinib Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Imatinib Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Capsules
  1.2.4 Tablets
1.3 Asia-Pacific Imatinib Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Imatinib Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospitals
  1.3.3 Drug Stores
  1.3.4 Other
1.4 Asia-Pacific Imatinib Drugs Market by Region
  1.4.1 Asia-Pacific Imatinib Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Imatinib Drugs (2012-2022)
  1.5.1 Asia-Pacific Imatinib Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Imatinib Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC IMATINIB DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Imatinib Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Imatinib Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Imatinib Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Imatinib Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Imatinib Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Imatinib Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Imatinib Drugs (Volume) by Application
2.4 Asia-Pacific Imatinib Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Imatinib Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Imatinib Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Imatinib Drugs Sales and Value (2012-2017)
  3.1.1 China Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Imatinib Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Imatinib Drugs Sales Price Trend (2012-2017)
3.2 China Imatinib Drugs Sales Volume and Market Share by Type
3.3 China Imatinib Drugs Sales Volume and Market Share by Application

4 JAPAN IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Imatinib Drugs Sales and Value (2012-2017)
  4.1.1 Japan Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Imatinib Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Imatinib Drugs Sales Price Trend (2012-2017)
4.2 Japan Imatinib Drugs Sales Volume and Market Share by Type
4.3 Japan Imatinib Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Imatinib Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Imatinib Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Imatinib Drugs Sales Price Trend (2012-2017)
5.2 South Korea Imatinib Drugs Sales Volume and Market Share by Type
5.3 South Korea Imatinib Drugs Sales Volume and Market Share by Application

6 TAIWAN IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Imatinib Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Imatinib Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Imatinib Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Imatinib Drugs Sales Volume and Market Share by Type
6.3 Taiwan Imatinib Drugs Sales Volume and Market Share by Application

7 INDIA IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Imatinib Drugs Sales and Value (2012-2017)
  7.1.1 India Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Imatinib Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Imatinib Drugs Sales Price Trend (2012-2017)
7.2 India Imatinib Drugs Sales Volume and Market Share by Type
7.3 India Imatinib Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Imatinib Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Imatinib Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Imatinib Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Imatinib Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Imatinib Drugs Sales Volume and Market Share by Application

9 AUSTRALIA IMATINIB DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Imatinib Drugs Sales and Value (2012-2017)
  9.1.1 Australia Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Imatinib Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Imatinib Drugs Sales Price Trend (2012-2017)
9.2 Australia Imatinib Drugs Sales Volume and Market Share by Type
9.3 Australia Imatinib Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC IMATINIB DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Apotex Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Imatinib Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Imatinib Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Novartis Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Sanofi S.A.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Imatinib Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Cipla Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Imatinib Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Mylan Pharms Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Imatinib Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Glenmark Pharmaceuticals Ltd.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Imatinib Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Sun Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Imatinib Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Actavis Generics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Imatinib Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Dr. Reddy's Laboratories
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Imatinib Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Teva Pharmaceutical Industries Ltd.
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Imatinib Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 IMATINIB DRUGS MANUFACTURING COST ANALYSIS

11.1 Imatinib Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Imatinib Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Imatinib Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Imatinib Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC IMATINIB DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Imatinib Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Imatinib Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Imatinib Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Imatinib Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Imatinib Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Imatinib Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Imatinib Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Imatinib Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Imatinib Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Imatinib Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Imatinib Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Imatinib Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Imatinib Drugs
Figure Asia-Pacific Imatinib Drugs Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Imatinib Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsules Product Picture
Figure Tablets Product Picture
Figure Asia-Pacific Imatinib Drugs Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Imatinib Drugs by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Drug Stores Examples
Table Key Downstream Customer in Drug Stores
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Imatinib Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Imatinib Drugs Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Imatinib Drugs Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Imatinib Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Imatinib Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Imatinib Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Imatinib Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Imatinib Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Imatinib Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Imatinib Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Imatinib Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Imatinib Drugs Revenue Share by Players
Table Asia-Pacific Imatinib Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Imatinib Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Imatinib Drugs by Type (2012-2017)
Figure Asia-Pacific Imatinib Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Imatinib Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Imatinib Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Imatinib Drugs by Type (2012-2017)
Figure Asia-Pacific Imatinib Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Imatinib Drugs Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Imatinib Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Imatinib Drugs by Region (2012-2017)
Figure Asia-Pacific Imatinib Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Imatinib Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Imatinib Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Imatinib Drugs by Region (2012-2017)
Figure Asia-Pacific Imatinib Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Imatinib Drugs Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Imatinib Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Imatinib Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Imatinib Drugs Sales Market Share by Application (2012-2017)
Figure China Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure China Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table China Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table China Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Imatinib Drugs Sales Volume Market Share by Type in 2016
Table China Imatinib Drugs Sales Volume (MT) by Applications (2012-2017)
Table China Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Imatinib Drugs Sales Volume Market Share by Application in 2016
Figure Japan Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Japan Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table Japan Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Imatinib Drugs Sales Volume Market Share by Type in 2016
Table Japan Imatinib Drugs Sales Volume (MT) by Applications (2012-2017)
Table Japan Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Imatinib Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table South Korea Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table South Korea Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Imatinib Drugs Sales Volume Market Share by Type in 2016
Table South Korea Imatinib Drugs Sales Volume (MT) by Applications (2012-2017)
Table South Korea Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Imatinib Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Taiwan Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table Taiwan Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Imatinib Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Imatinib Drugs Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Imatinib Drugs Sales Volume Market Share by Application in 2016
Figure India Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure India Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table India Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table India Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Imatinib Drugs Sales Volume Market Share by Type in 2016
Table India Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
Table India Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Imatinib Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Imatinib Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Imatinib Drugs Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Imatinib Drugs Sales Volume Market Share by Application in 2016
Figure Australia Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Australia Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Australia Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
Table Australia Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Imatinib Drugs Sales Volume Market Share by Type in 2016
Table Australia Imatinib Drugs Sales Volume (MT) by Applications (2012-2017)
Table Australia Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Imatinib Drugs Sales Volume Market Share by Application in 2016
Table Apotex Inc. Imatinib Drugs Basic Information List
Table Apotex Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Apotex Inc. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Apotex Inc. Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Apotex Inc. Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Imatinib Drugs Basic Information List
Table Novartis Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Novartis Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi S.A. Imatinib Drugs Basic Information List
Table Sanofi S.A. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi S.A. Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi S.A. Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Cipla Inc. Imatinib Drugs Basic Information List
Table Cipla Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Cipla Inc. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Cipla Inc. Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Cipla Inc. Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Mylan Pharms Inc. Imatinib Drugs Basic Information List
Table Mylan Pharms Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Mylan Pharms Inc. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Mylan Pharms Inc. Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Mylan Pharms Inc. Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Basic Information List
Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sun Pharmaceuticals Imatinib Drugs Basic Information List
Table Sun Pharmaceuticals Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sun Pharmaceuticals Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sun Pharmaceuticals Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sun Pharmaceuticals Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Actavis Generics Imatinib Drugs Basic Information List
Table Actavis Generics Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Actavis Generics Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Actavis Generics Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Actavis Generics Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Dr. Reddy's Laboratories Imatinib Drugs Basic Information List
Table Dr. Reddy's Laboratories Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Dr. Reddy's Laboratories Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Basic Information List
Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Imatinib Drugs
Figure Manufacturing Process Analysis of Imatinib Drugs
Figure Imatinib Drugs Industrial Chain Analysis
Table Raw Materials Sources of Imatinib Drugs Major Manufacturers in 2016
Table Major Buyers of Imatinib Drugs
Table Distributors/Traders List
Figure Asia-Pacific Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Imatinib Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table Asia-Pacific Imatinib Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Imatinib Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Imatinib Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Imatinib Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Imatinib Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Imatinib Drugs Revenue Market Share Forecast by Region in 2022
Figure China Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Imatinib Drugs Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Imatinib Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Imatinib Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Imatinib Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Imatinib Drugs Price (USD/Kg) Forecast by Type (2017-2022)
Table Asia-Pacific Imatinib Drugs Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Imatinib Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories